RNU7-190P

Across TCGA pan-cancer cohorts, RNU7-190P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU7-190P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RNU7-190P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-190P expression acts as an unfavorable survival marker.

LUSC, KIRC, and UCEC are the cancer types where RNU7-190P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	II,III,IV	0.178	0.743	.004	81	view →
KIRC	DFS	Tertile	III,IV	0.127	0.744	.002	72	view →
UCEC	OS	Tertile	II,III,IV	0.156	0.768	<.001	72	view →
ESCA	DFS	Tertile	All	0.309	0.538	.001	66	view →
COAD	DFS	Tertile	III,IV	0.005	0.650	<.001	27	view →
TGCT	DFS	Tertile	All	0.099	0.801	.011	18	view →
SKCM	OS	Tertile	All	0.198	0.335	.013	15	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU7-190P–LUSC (OS)

Open the LUSC breakdown →